ReviewHIV/AIDS (Auckland, N.Z.)2026
Research Trends in HIV-Associated Nephropathy (HIVAN) from 2015 to 2025: A Bibliometric Analysis Using CiteSpace.
Review in HIV/AIDS (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, HIV-associated nephropathy (HIVAN) has significantly impacted the compliance, quality of life, and treatment outcomes for patients with AIDS. This study employs CiteSpace bibliometric analysis to predict emerging topics and research trends, thereby offering clear scientific navigation and strategic recommendations for HIVAN research. Methods: We retrieved publications related to HIVAN from the Web of Science Core Collection covering the period from 2015 to 2025. Utilizing CiteSpace, we analyzed the co-occurrence network, clustering,and timeline of research trends in this field to illustrate the knowledge evolution surrounding HIVAN. Results: A total of 1,470 publications were included from 2015 to 2025. The United States maintained its dominant position in medical research, while countries such as the United Kingdom, South Africa, France, and China emerged as key contributors in the field. Prominent institutions, including the University of California system, Johns Hopkins University, and University of the London, were central to HIVAN research. Scholars such as Estrella, Michelle M. Shlipak, Michael G. and Kopp, Jeffrey B exhibited substantial academic output and garnered considerable citation attention. Leading journals, including "Clinical Infectious Diseases", "PLOS ONE" and "AIDS" served as premier venues for review articles, providing essential platforms and establishing foundations for ongoing research. The research activity and academic impact of HIVAN within the sub-discipline of nephrology currently represent prominent areas of inquiry. Conclusion: This study examined the knowledge network structure of HIVAN from 2015 to 2025 examined bibliometric analysis. Future research should focus on enhancing international collaboration, particularly in resource limited regions, to investigate various intervention strategies aimed at improving compliance, quality of life, and treatment outcomes for HIVAN patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.